Neuroprotective Effect of Riboflavin Producing Lactic Acid Bacteria in Parkinsonian Models
Abstract Oxidative stress and inflammatory processes might contribute to the cascade of events leading Parkinson disease (PD); and vitamins such as riboflavin can exert protection on vulnerable neurons in neurodegenerative conditions. Previously, it was demonstrated that a mixture of lactic acid bacteria (including a riboflavin-producing strain) improved motor skills in a parkinsonian model. The aim of the present work was to investigate the neuroprotective potential of Lactiplantibacillus (L.) plantarum CRL2130, a riboflavin-producing strain in PD models. In vitro, N2a differentiated neurons were exposed the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) and treated with intracellular bacterial extracts or commercial riboflavin. In vivo, adult male C57BL/6 mice were injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and probenecid, and received orally L. plantarum CRL2130, L. plantarum CRL725 (parent strain that produces low levels of riboflavin) or commercial vitamin. Results showed that when N2a cells were incubated with intracellular extract from L. plantarum CRL2130 maintained the viability, and significantly decreased the release of IL-6 and the formation of reactive oxygen species (ROS), all affected by MPP+. In vivo, the administration of L. plantarum CRL2130 attenuated motor deficits and prevented dopaminergic neuronal death. Decrease of pro-inflammatory cytokines and increase of IL-10 in both serum and brain were observed in samples from mice that received L. plantarum CRL2130 compared to MPTP control group (without treatment). In addition, these beneficial effects were similar or improved when compared with animals that received commercial riboflavin. In conclusion, L. plantarum CRL2130 showed a neuroprotective effect in both PD models through anti-oxidant/anti-inflammatory mechanisms..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
|---|---|
| Enthalten in: |
Neurochemical research - 47(2022), 5 vom: 03. Feb., Seite 1269-1279 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Perez Visñuk, Daiana [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
Animal model |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 |
|---|
| doi: |
10.1007/s11064-021-03520-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
SPR046618309 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR046618309 | ||
| 003 | DE-627 | ||
| 005 | 20230519182136.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220330s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11064-021-03520-w |2 doi | |
| 035 | |a (DE-627)SPR046618309 | ||
| 035 | |a (SPR)s11064-021-03520-w-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Perez Visñuk, Daiana |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neuroprotective Effect of Riboflavin Producing Lactic Acid Bacteria in Parkinsonian Models |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2022 | ||
| 520 | |a Abstract Oxidative stress and inflammatory processes might contribute to the cascade of events leading Parkinson disease (PD); and vitamins such as riboflavin can exert protection on vulnerable neurons in neurodegenerative conditions. Previously, it was demonstrated that a mixture of lactic acid bacteria (including a riboflavin-producing strain) improved motor skills in a parkinsonian model. The aim of the present work was to investigate the neuroprotective potential of Lactiplantibacillus (L.) plantarum CRL2130, a riboflavin-producing strain in PD models. In vitro, N2a differentiated neurons were exposed the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) and treated with intracellular bacterial extracts or commercial riboflavin. In vivo, adult male C57BL/6 mice were injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and probenecid, and received orally L. plantarum CRL2130, L. plantarum CRL725 (parent strain that produces low levels of riboflavin) or commercial vitamin. Results showed that when N2a cells were incubated with intracellular extract from L. plantarum CRL2130 maintained the viability, and significantly decreased the release of IL-6 and the formation of reactive oxygen species (ROS), all affected by MPP+. In vivo, the administration of L. plantarum CRL2130 attenuated motor deficits and prevented dopaminergic neuronal death. Decrease of pro-inflammatory cytokines and increase of IL-10 in both serum and brain were observed in samples from mice that received L. plantarum CRL2130 compared to MPTP control group (without treatment). In addition, these beneficial effects were similar or improved when compared with animals that received commercial riboflavin. In conclusion, L. plantarum CRL2130 showed a neuroprotective effect in both PD models through anti-oxidant/anti-inflammatory mechanisms. | ||
| 650 | 4 | |a Vitamin B2 |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Parkinson’s disease |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a N2a cells |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Motor behavior |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Animal model |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Anti-oxidant effect |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Cytokines |7 (dpeaa)DE-He213 | |
| 700 | 1 | |a Teran, María del Milagro |4 aut | |
| 700 | 1 | |a Savoy de Giori, Graciela |4 aut | |
| 700 | 1 | |a LeBlanc, Jean Guy |4 aut | |
| 700 | 1 | |a de Moreno de LeBlanc, Alejandra |0 (orcid)0000-0003-0352-374X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurochemical research |d Dordrecht [u.a.] : Springer Science + Business Media B.V, 1976 |g 47(2022), 5 vom: 03. Feb., Seite 1269-1279 |w (DE-627)SPR016233697 |w (DE-600)2018503-0 |x 1573-6903 |7 nnns |
| 773 | 1 | 8 | |g volume:47 |g year:2022 |g number:5 |g day:03 |g month:02 |g pages:1269-1279 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1007/s11064-021-03520-w |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 47 |j 2022 |e 5 |b 03 |c 02 |h 1269-1279 | ||